ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q4 2023 Earnings Call Transcript July 7, 2023
ImmunoPrecise Antibodies Ltd. reports earnings inline with expectations. Reported EPS is $-0.17 EPS, expectations were $-0.17.
Operator: Good morning, ladies and gentlemen. Thank you for joining us today for IPA’s earnings call covering the fourth quarter and full fiscal year of 2023. I am Regina, and I have the privilege of hosting this call. Before we commence, I would like to draw your attention to...
